The Optispan Podcast with Matt Kaeberlein cover image

New Discovery: This Molecule Could Beat Rapamycin in Longevity

The Optispan Podcast with Matt Kaeberlein

00:00

Scale vs. existing testing programs

Matt contrasts Aura's low-cost, high-scale screening with larger, slower programs like the CITP and ITP.

Play episode from 17:03
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app